LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1Cohance Lifesciences
03 1Chemische Fabrik Berg
04 1DKSH
05 1Dr. Reddy's Laboratories
06 1Jai Radhe Sales
07 1Moehs Iberica
08 1HRV Global Life Sciences
09 1Tenatra Chemie
10 1Zeon Pharma Industries India Pvt Ltd
11 1Almelo
12 1Apotex Pharmachem
13 1Aurobindo Pharma Limited
14 1BASF
15 1CHEMO
16 1Cilag AG
17 1Cipla
18 1DEAFARMA
19 1Daito Pharmaceutical
20 1Fareva
21 1Guangzhou Tosun Pharmaceutical
22 1Hana Pharm
23 1KyungDong Pharm
24 2Midas Pharma
25 2Nifty Labs
26 1Nosch Labs Pvt
27 1Permachem
28 1Permachem Asia, Ltd
29 2Pfizer Inc
30 1Saneca Pharmaceuticals
31 1Srini Pharmaceuticals
32 1Standard Chem. & Pharm. Co., Ltd
33 1Synergene Active Ingredients Pvt Ltd
34 1Therapiva
35 1Unichem Laboratories Limited
36 1Unipex
37 1Viatris
38 1Wockhardt
39 1Zhejiang Lepu Pharmaceutical
40 1Zhejiang Neo-Dankong Pharm. Co.,Ltd.
41 1Blank
Reset all filters
01 1Canada
02 4China
03 1France
04 4Germany
05 17India
06 1Italy
07 3Japan
08 1Luxembourg
09 1Slovakia
10 2South Korea
11 2Spain
12 2Switzerland
13 4U.S.A
14 1Blank
Reset all filters
01 6Active
02 6Inactive
03 32Blank
01 8Valid
02 36Blank
Reset all filters
01 1217MF10662
02 1217MF11138
03 1218MF10433
04 1218MF10823
05 1218MF10903
06 1228MF10017
07 1305MF10107
08 37Blank
Reset all filters
01 1WC-0027
02 1WC-0120
03 1WC-0150
04 1WC-026n
05 1WC-0313
06 1WC-0316n
07 1WC-316
08 37Blank
Reset all filters
01 120050831-14-B-58-02
02 120050831-14-B-60-04
03 120080110-14-B-275-06
04 120110331-14-B-312-07
05 120221024-14-B-469-08
06 39Blank
Reset all filters
01 117511-113
02 146014-1001
03 153747-076
04 155111-005
05 165427-018
06 165862-204
07 168724-1001
08 37Blank
01 44Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-31
Pay. Date : 2019-12-23
DMF Number : 22941
Submission : 2009-07-10
Status : Active
Type : II
Certificate Number : CEP 2010-312 - Rev 03
Issue Date : 2023-10-27
Type : Chemical
Substance Number : 2125
Status : Valid
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
NDC Package Code : 17511-113
Start Marketing Date : 2009-07-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Available Reg Filing : CN, RU |
Certificate Number : CEP 2022-316 - Rev 00
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 2125
Status : Valid
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-28
Pay. Date : 2023-03-08
DMF Number : 12750
Submission : 1997-11-14
Status : Active
Type : II
NDC Package Code : 55111-005
Start Marketing Date : 1999-11-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : BR |
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
43
PharmaCompass offers a list of Doxazosin Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxazosin Mesylate manufacturer or Doxazosin Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxazosin Mesylate manufacturer or Doxazosin Mesylate supplier.
PharmaCompass also assists you with knowing the Doxazosin Mesylate API Price utilized in the formulation of products. Doxazosin Mesylate API Price is not always fixed or binding as the Doxazosin Mesylate Price is obtained through a variety of data sources. The Doxazosin Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxazosin Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxazosin Mesylate, including repackagers and relabelers. The FDA regulates Doxazosin Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxazosin Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxazosin Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxazosin Mesylate supplier is an individual or a company that provides Doxazosin Mesylate active pharmaceutical ingredient (API) or Doxazosin Mesylate finished formulations upon request. The Doxazosin Mesylate suppliers may include Doxazosin Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Doxazosin Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 40 companies offering Doxazosin Mesylate
Get in contact with the supplier of your choice: